The cost of inadequate prescriptions for hypolipidaemic drugs. VICAF Group

The high consumption of hypolipidaemic agents warrants the study of the costs caused by these medicines being inadequately prescribed. To quantify the economic cost generated in 1 year in primary care by inadequate (or unnecessary) prescriptions for hypolipidaemic drugs. A cross-sectional study base...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PharmacoEconomics 2001, Vol.19 (5 Pt 1), p.513-522
Hauptverfasser:	Ballesteros, L C, Fernández San Martín, M I, Sanz Cuesta, T, Escortell Mayor, E, López Bilbao, C
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Cross-Sectional Studies Drug Prescriptions - economics Drug Prescriptions - statistics & numerical data Female Health technology assessment Humans Hyperlipidemias - diet therapy Hyperlipidemias - drug therapy Hyperlipidemias - prevention & control Hypolipidemic Agents - administration & dosage Hypolipidemic Agents - economics Male Middle Aged Primary Health Care - economics Risk Factors Spain
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!